Small-for-gestational age (SGA) neonates exhibit increased perinatal morbidity and mortality, and a greater risk of developing chronic diseases in adulthood. Currently, no effective maternal blood-based screening methods for determining SGA risk are available. We used a high-resolution MS/MSALL shotgun lipidomic approach to explore the lipid profiles of small extracellular vesicles (sEV) released from the placenta into the circulation of pregnant individuals. Samples were acquired from 195 normal and 41 SGA pregnancies. Lipid profiles were determined serially across pregnancy. We identified specific lipid signatures of placental sEVs that define the trajectory of a normal pregnancy and their changes occurring in relation to maternal characteristics (parity and ethnicity) and birthweight centile. We constructed a multivariate model demonstrating that specific lipid features of circulating placental sEVs, particularly during early gestation, are highly predictive of SGA infants. Lipidomic-based biomarker development promises to improve the early detection of pregnancies at risk of developing SGA, an unmet clinical need in obstetrics.Distinct lipid signatures of circulating placenta-derived sEVs define the trajectory of a healthy pregnancy and identify SGA risk in the first trimester of gestation. double dagger image

Klemetti, M.M., Pettersson, A.B.V., Ahmad Khan, A., Ermini, L., Porter, T.R., Litvack, M.L., et al. (2024). Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk. JOURNAL OF EXTRACELLULAR VESICLES, 13(2) [10.1002/jev2.12413].

Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk

Ermini, Leonardo;
2024-01-01

Abstract

Small-for-gestational age (SGA) neonates exhibit increased perinatal morbidity and mortality, and a greater risk of developing chronic diseases in adulthood. Currently, no effective maternal blood-based screening methods for determining SGA risk are available. We used a high-resolution MS/MSALL shotgun lipidomic approach to explore the lipid profiles of small extracellular vesicles (sEV) released from the placenta into the circulation of pregnant individuals. Samples were acquired from 195 normal and 41 SGA pregnancies. Lipid profiles were determined serially across pregnancy. We identified specific lipid signatures of placental sEVs that define the trajectory of a normal pregnancy and their changes occurring in relation to maternal characteristics (parity and ethnicity) and birthweight centile. We constructed a multivariate model demonstrating that specific lipid features of circulating placental sEVs, particularly during early gestation, are highly predictive of SGA infants. Lipidomic-based biomarker development promises to improve the early detection of pregnancies at risk of developing SGA, an unmet clinical need in obstetrics.Distinct lipid signatures of circulating placenta-derived sEVs define the trajectory of a healthy pregnancy and identify SGA risk in the first trimester of gestation. double dagger image
2024
Klemetti, M.M., Pettersson, A.B.V., Ahmad Khan, A., Ermini, L., Porter, T.R., Litvack, M.L., et al. (2024). Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk. JOURNAL OF EXTRACELLULAR VESICLES, 13(2) [10.1002/jev2.12413].
File in questo prodotto:
File Dimensione Formato  
J of Extracellular Vesicle - 2024 - Klemetti - Lipid profile of circulating placental extracellular vesicles during.pdf

accesso aperto

Tipologia: PDF editoriale
Licenza: Creative commons
Dimensione 9.3 MB
Formato Adobe PDF
9.3 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1256218